德展健康
(000813)
| 流通市值：84.92亿 | | | 总市值：84.93亿 |
| 流通股本：20.97亿 | | | 总股本：20.97亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 166,356,232.73 | 89,277,784.01 | 466,485,016.5 | 354,472,693.3 |
| 营业收入 | 166,356,232.73 | 89,277,784.01 | 466,485,016.5 | 354,472,693.3 |
| 二、营业总成本 | 204,976,889.22 | 99,442,024.53 | 476,549,833.05 | 333,494,551.73 |
| 营业成本 | 75,278,769.99 | 35,871,518.81 | 167,336,906.51 | 136,624,067.32 |
| 税金及附加 | 4,918,809.34 | 3,012,585.83 | 10,543,283.71 | 8,350,475.34 |
| 销售费用 | 34,997,432.02 | 17,829,317.86 | 85,654,355.73 | 61,587,510.18 |
| 管理费用 | 96,605,987.67 | 45,146,304.5 | 210,278,491.88 | 141,503,107.32 |
| 研发费用 | 18,494,645.01 | 10,024,839.12 | 68,369,450.44 | 36,148,711.02 |
| 财务费用 | -25,318,754.81 | -12,442,541.59 | -65,632,655.22 | -50,719,319.45 |
| 其中:利息费用 | 563,578.02 | 120,086.23 | 371,350.95 | 283,269.54 |
| 其中:利息收入 | 26,118,798.08 | 12,683,124.61 | 66,360,531.8 | 51,084,143.81 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | -10,238,855.34 | -3,976,605.05 | -19,870,783.27 | -10,162,176.84 |
| 资产处置收益 | 394.81 | 394.81 | -23,847.13 | -3,216.54 |
| 资产减值损失(新) | -7,904.1 | -125,289.4 | -385,209.89 | -449,442.05 |
| 信用减值损失(新) | -7,340,386.81 | -13,497,175.31 | -15,762,757.46 | -13,340,597.34 |
| 其他收益 | 3,130,954.08 | 2,066,921.45 | 3,626,403.43 | 2,986,924.45 |
| 四、营业利润 | -53,076,453.85 | -25,695,994.02 | -42,481,010.87 | 9,633.25 |
| 加:营业外收入 | 23,409.49 | 14,802.43 | 35,072.4 | 14,518.24 |
| 减:营业外支出 | 309,712.41 | 52,091.54 | 1,668,061.42 | 986,186.64 |
| 五、利润总额 | -53,362,756.77 | -25,733,283.13 | -44,113,999.89 | -962,035.15 |
| 减:所得税费用 | 6,410,536.39 | 3,542,929.69 | -1,894,136.65 | 7,367,120.87 |
| 六、净利润 | -59,773,293.16 | -29,276,212.82 | -42,219,863.24 | -8,329,156.02 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -59,773,293.16 | -29,276,212.82 | -42,219,863.24 | -8,329,156.02 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -42,926,483.17 | -22,114,871.36 | -20,413,065.61 | 8,089,554.12 |
| 少数股东损益 | -16,846,809.99 | -7,161,341.46 | -21,806,797.63 | -16,418,710.14 |
| 扣除非经常损益后的净利润 | -45,493,242.75 | -23,901,953.82 | -23,696,740.02 | 4,611,154.39 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.02 | -0.01 | -0.01 | 0 |
| (二)稀释每股收益 | -0.02 | -0.01 | -0.01 | 0 |
| 八、其他综合收益 | - | - | -28,274,400 | - |
| 归属于母公司股东的其他综合收益 | - | - | -28,274,400 | - |
| 九、综合收益总额 | -59,773,293.16 | -29,276,212.82 | -70,494,263.24 | -8,329,156.02 |
| 归属于母公司股东的综合收益总额 | -42,926,483.17 | -22,114,871.36 | -48,687,465.61 | 8,089,554.12 |
| 归属于少数股东的综合收益总额 | -16,846,809.99 | -7,161,341.46 | -21,806,797.63 | -16,418,710.14 |
| 公告日期 | 2025-08-23 | 2025-04-29 | 2025-04-29 | 2024-10-31 |
| 审计意见(境内) | | | 标准无保留意见 | |